|
- IRMS - Nicolae Testemitanu SUMPh
- 1. COLECȚIA INSTITUȚIONALĂ
- MedEspera: International Medical Congress for Students and Young Doctors
- MedEspera 2014
Please use this identifier to cite or link to this item:
http://hdl.handle.net/20.500.12710/19458
Title: | Dressler's syndrome after myocardial infarction |
Authors: | Grib, Andrei Abraș, Marcel Morkunaite, Kristina Lapinskas, Tomas |
Keywords: | Dressier syndrome;myocardial infarction |
Issue Date: | 2014 |
Publisher: | Ministry of Health of the Republic of Moldova, State Medical and Pharmaceutical University Nicolae Testemitanu, Medical Students and Residents Association |
Citation: | GRIB, Andrei, ABRAŞ, Marcel, MORKUNAITE, Kristina, LAPINSKAS, Tomas. Dressler's syndrome after myocardial infarction. In: MedEspera: the 5th Internat. Medical Congress for Students and Young Doctors: abstract book. Chișinău: S. n., 2014, p. 62. |
Abstract: | Introduction: Dressler's syndrome is a secondary form of pericarditis following myocardial
infarction (MI) or postsurgical injury of the pericardium. It presents with fever, pleuritic pain and
pericardial effusion between 2 weeks to several months after MI, and is affecting 1-5% of patients.
Case Report: A 37-year-old male presented to the emergency room (ER) with acute chest pain,
accompanied by general weakness after 18 hours from onset of symptoms. Cardiac risk factors included
hypertension, smoking, dyslipidemia and a family history of coronary artery disease. The ECG was
consistent with an acute inferior ST-segment elevation MI. Despite the late presentation, he was taken to
the catheterization lab because of his ongoing pain and persistent ST elevation. Coronary angiography
revealed proximal circumflex artery occlusion. Target lesion angioplasty was performed and a bare
metal stent (INTEGRITY 3.5x15 mm) was implanted, obtaining a successful opening of the artery with
a TIMI 3 flow. Following loading doses of aspirin and Clopidogrel in the ER, the treatment continued
with Metoprolol, Zofenopril, Atorvastatin and Heparin. Level of troponin I was elevated to 166.23 pg/1.
Transthoracic echocardiogram (EcoCG) showed akinesis of the inferior, posterior and lateral walls of
the left ventricle (LV) from the base to the apex with a reduced systolic function (EF 35%) and no
pericardial effusion. His impatient stay was complicated by pyrexia, raised inflammatory markers (CRP
239.72 mg/1) and a negative chest X-ray dynamic with worsening venous stasis to grade 2, focal
infiltration in the right 7th and 8th segments and minimal amount of pleural fluid. A right lung lower and
middle lobes pneumonia was diagnosed and antibacterial therapy (Ampicillin/Sulbactam 1.5 g * 4
times/day) was added. Further laboratory findings revealed mild anemia, leukocytosis, raised
inflammatory and liver markers. Sputum culture was negative. Two weeks after admission, despite
antibiotic therapy, the patient continued to have fever, dyspnea, dry cough and pleuritic pain. EcoCG
examination showed progressive pericardial effusion with no visible mechanical defects. Subsequent
cardiac magnetic resonance revealed pericardial effusion of heterogeneous fluid: LV lateral wall 28 mm,
inferior wall 22 mm, anterior wall 27 mm, right ventricle lateral wall 20 mm, left atrium 30 mm, right
atrium 24 mm, with its systolic collapse. Pericardiocentesis for decompression was not performed
because of no clinical signs of hemodynamic compromise. In the absence of sufficient data for a
“hidden” cardiac rupture and the presence of rich pericardial fluid accumulation, a diagnosis of
Dressler's syndrome was considered, and a glucocorticoid therapy with Prednisolone 1 mg/kg/day was
initiated. Because of persistent inflammatory indicators, antibacterial treatment was changed to
Piperacillin/Tazobactam 4.5 g x 4 times/day. During the next few days on treatment patients’ fever
subsided, cough and dyspnea were reduced. Heart rate normalized to 74 beats/min and blood pressure
was 120/70 mmHg. Auscultation revealed vesicular breathing in the lungs, without rales. A
prednisolone dose reduction to 5 mg/week was recommended to be continued after discharge. One
month later the patient presented to the hospital for reevaluation and he had no recurrence of pericardial
symptoms and a repeated EcoCG showed no pericardial effusion. |
metadata.dc.relation.ispartof: | MedEspera: The 5th International Medical Congress for Students and Young Doctors, May 14-17, 2014, Chisinau, Republic of Moldova |
URI: | http://repository.usmf.md/handle/20.500.12710/19458 |
Appears in Collections: | MedEspera 2014
|
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.
|